SCHEMBL4693015

SCHEMBL4693015

OC(OCc1ccccc1)C1CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 3/20 0.47
SLC6A4 P31645 3/20 0.47
SLC6A3 Q01959 3/20 0.47
SLC1A3 P43003 2/20 0.42
SLC1A2 P43004 2/20 0.42
SLC1A1 P43005 2/20 0.42
CYP2C9 P11712 2/20 0.42
CYP2C19 P33261 2/20 0.42
MEN1 O00255 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2D6 P10635 1/20 0.42
KMT2A Q03164 1/20 0.42
TSHR P16473 1/20 0.41
CA1 P00915 3/20 0.41
CA2 P00918 1/20 0.41
CA7 P43166 1/20 0.41
CA9 Q16790 1/20 0.41
CYP3A4 P08684 1/20 0.40
POLB P06746 1/20 0.39
IDO1 P14902 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1355001 0.91 SLC6A2 (0.44) SLC6A2SLC6A4SLC6A3CYP2C9CYP2C19
SCHEMBL21702403 0.85 SLC6A2 (0.38) SLC6A2SLC6A4SLC6A3SLC1A3SLC1A2
SCHEMBL20602091 0.84 SLC6A2 (0.44) SLC6A2SLC6A4SLC6A3SLC1A3SLC1A2
SCHEMBL12465315 0.77 MAPT (0.42) SLC6A2SLC6A4SLC6A3SLC1A3SLC1A2
SCHEMBL4693009 0.77 SLC6A2 (0.47) SLC6A2SLC6A4SLC6A3SLC1A3SLC1A2
SCHEMBL6774653 0.74 TSHR (0.52) SLC6A2SLC6A4SLC6A3SLC1A3SLC1A2
SCHEMBL3811153 0.74 SLC6A2 (0.45) SLC6A2SLC6A4SLC6A3SLC1A3SLC1A2
SCHEMBL22183791 0.74 TAAR1 (0.44) MEN1CYP1A2CYP2D6KMT2ATSHR
SCHEMBL24038017 0.73 CYP2C19 (0.54) SLC6A2SLC6A3CYP2C9CYP2C19MEN1
SCHEMBL21915824 0.73 CYP2C19 (0.54) SLC6A2SLC6A3CYP2C9CYP2C19MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1296973-B1 GUANIDINE DERIVATIVES OF QUINAZOLINE FOR USE IN THE TREATMENT OF AUTOIMMUNE DISEASES ASTRAZENECA AB (SE) 2008-11-05 EP claimed